Shiranee Sriskandan - Infectious Diseases

Author Information

Shiranee Sriskandan is a prominent researcher in the field of Infectious Diseases, affiliated with the Section of Infectious Diseases and Immunity at the Department of Medicine, Imperial College London, UK. Her research primarily focuses on the epidemiology, transmission, and treatment of infectious diseases, with particular attention to bacterial infections and emerging viral threats such as COVID-19.

Research Contributions

Shiranee Sriskandan has made significant contributions to understanding the transmission dynamics and risk factors associated with infectious diseases. Her work includes studies on the transmission and epidemiology of Streptococcus pyogenes among schoolchildren, the characterization of antibiotic-resistant bacteria, and the clinical management of COVID-19. Notably, her research has contributed to the development and implementation of clinical models and protocols to improve patient outcomes during pandemics. Her studies often employ molecular epidemiological methods and large cohort analyses, providing valuable insights into infection control and public health strategies.

Aliases

Shiranee Sriskandan is also known by several aliases in academic publications, including S Sriskandan, S. M. Sriskandan, and S. Sriskandan. These variations are often used interchangeably in her scholarly work.

Publication and Citation Metrics

Metric	Value
Total Papers	263
Citation Count	7749
H-index	49

Publications:

Frequency of transmission, asymptomatic shedding, and airborne spread of Streptococcus pyogenes in schoolchildren exposed to scarlet fever: a prospective, longitudinal, multicohort, molecular epidemiological, contact-tracing study in England, UK

DOI: 10.1016/s2666-5247(21)00332-3

Year: 2022

Detection and characterisation of 16S rRNA methyltransferase-producing Pseudomonas aeruginosa from the UK and Republic of Ireland from 2003-2015.

DOI: 10.1016/j.ijantimicag.2022.106550

Year: 2022

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

DOI: 10.1016/S2589-7500(22)00018-8

Year: 2022

Antiviral metabolite 3′-deoxy-3′,4′-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19

DOI: 10.1016/j.medj.2022.01.009

Year: 2022

Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study.

DOI: 10.1093/jac/dkac071

Year: 2022

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

DOI: 10.1016/S2213-2600(21)00175-2

Year: 2021

High frequency transmission, asymptomatic shedding, and airborne spread of Streptococcus pyogenes among schoolchildren exposed to scarlet fever: a longitudinal multi-cohort moleculo-epidemiological contact tracing study.

DOI: 10.1101/2021.07.04.21259990

Year: 2021

A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UK.

DOI: 10.1093/jac/dkab186

Year: 2021

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

DOI: 10.1016/S2213-2600(20)30559-2

Year: 2021

The value of open-source clinical science in pandemic response: lessons from ISARIC

DOI: 10.1016/S1473-3099(21)00565-X

Year: 2021

What are the Symptoms of HSV?

Why is Quarantine Necessary?

What are Commonly Used ACTs?

How to Interpret Chest CT Scan Results?

Which Microorganisms Commonly Colonize Humans?

What Types of Pathogens are Commonly Spread by Direct Contact?

How Can HSV Be Prevented?

How is HSV Transmitted?

What should be done upon return from travel?

How to Diagnose a Rash?

Partnered Content Networks

Relevant Topics